PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
News|Articles|November 26, 2013
Almac Launches Logistics Support Services
Author(s)Pharmaceutical Technology Editors
Almac releases an enhanced third-party logistics customer billing application.
Advertisement
In response to client demand for end-to-end support of EU product launches, from import testing, country specific packaging, QP release, online ordering, direct to pharmacy distribution, and financial services, Almac have improved their customer billing software to facilitate an invoicing process on behalf of 3PL clients.
3PL orders, received directly from hospitals, clinics, and pharmacies for niche/orphan drug products, will now be processed, dispatched, and automatically invoiced on the client’s behalf. The process will be completed by reconciliation of payments to the client’s EU account, as well as debtor follow-up.
Source:
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement